Oct. 2 at 1:47 PM
$MDAI Without specific number projections yet from SAI Jimzi1's post is as insightful as it gets:
What many don’t get is FDA unleashes the massive mcap drivers: as Barda has funded the initial sales to the tune of
$93M to get to commercialisation,
$14.6B market and growing at 4.4% , GP 44.6%, DFU as big as cancer yet no modern diagnostic tool, global IPR covered, worlds largest wound database so replication not possible or worth it , massive hospital cost savings (hello insurance companies) and no competition save doctors running at 40% diagnoses success.
And don’t forget the US military contracts.
